Mitsui and Founders Fund provided the funding, which will support the consumer genomics company's international expansion.

Japan-based consumer genomics company Genesis Healthcare has received $5.1m in funding from conglomerate Mitsui and venture capital firm Founders Fund in return for a combined 6% stake, The Bridge reported on Wednesday.

Founded in 2004 as Weight Management, Genesis produces genetic testing kits that allow users to gain insights into their ancestry, predisposition for cancer, dietary fat intake and other genetics-based information.

The kit costs ¥29,800 ($243) and is sold in stores, and online by retailers including internet company Yahoo…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?